Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ARCT

Arcturus Therapeutics (ARCT)

Arcturus Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARCT
DateTimeSourceHeadlineSymbolCompany
13/09/202422:15PR Newswire (US)Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika PharmaNASDAQ:ARCTArcturus Therapeutics Holdings Inc
13/09/202422:00Business WireJapan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika PharmaNASDAQ:ARCTArcturus Therapeutics Holdings Inc
03/09/202422:30Business WireArcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic FibrosisNASDAQ:ARCTArcturus Therapeutics Holdings Inc
28/08/202407:00Business WireArcturus Therapeutics to Attend Upcoming Investor & Scientific ConferencesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
13/08/202421:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
06/08/202406:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARCTArcturus Therapeutics Holdings Inc
06/08/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
06/08/202406:01Business WireArcturus Therapeutics Announces Second Quarter 2024 Financial Update and Pipeline ProgressNASDAQ:ARCTArcturus Therapeutics Holdings Inc
02/08/202406:01Business WireArcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
19/07/202409:30Business WireArcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 5, 2024NASDAQ:ARCTArcturus Therapeutics Holdings Inc
18/07/202407:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ARCTArcturus Therapeutics Holdings Inc
02/07/202406:01Business WireArcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) ProgramsNASDAQ:ARCTArcturus Therapeutics Holdings Inc
20/06/202422:00Business WireArcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of DirectorsNASDAQ:ARCTArcturus Therapeutics Holdings Inc
19/06/202411:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
19/06/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
15/06/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/06/202400:30Business WireArcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
28/05/202420:30Business WireArcturus Therapeutics Announces Positive Development for Cystic Fibrosis ProgramNASDAQ:ARCTArcturus Therapeutics Holdings Inc
22/05/202421:00GlobeNewswire Inc.Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer VaccinesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
20/05/202422:30PR Newswire (US)Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 VaccineNASDAQ:ARCTArcturus Therapeutics Holdings Inc
20/05/202422:30Business WireNature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 VaccineNASDAQ:ARCTArcturus Therapeutics Holdings Inc
16/05/202406:01Business WireArcturus Therapeutics to Attend Upcoming Investor & Scientific ConferencesNASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/05/202406:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
09/05/202406:01Business WireArcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline ProgressNASDAQ:ARCTArcturus Therapeutics Holdings Inc
26/04/202406:01Business WireArcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 8, 2024NASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/03/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
08/03/202408:01Business WireArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline ProgressNASDAQ:ARCTArcturus Therapeutics Holdings Inc
27/02/202401:00Business WireArcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:ARCTArcturus Therapeutics Holdings Inc
24/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARCTArcturus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ARCT